Ownership
Private
Employees
~1700
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
ISDIN General Information
ISDIN’s products are widely used globally with clinical studies supporting efficacy for several lines. Their Eryfotona Actinica sunscreen contains photolyase enzyme to aid DNA repair post-sun exposure. The Isdinceutics line includes clinically tested anti-aging serums and targeted solutions for pigmentation and eye area concerns. U.S.-specific clinical data are being developed; European product studies are available.
Contact Information
Website
Primary Industry
Non-Drug Biotech
Corporate Office
Barcelona, Catalonia
Spain
Spain
Drug Pipeline
No pipeline data available
Key Partnerships
Works closely with dermatologists and pharmacists worldwide, member of various industry associations including Farma Industria Asociación Nacional Empresarial de la Industria Farmaceutica
ISDIN Funding
No funding data available
To view ISDIN's complete valuation and funding history, request access »
Gosset